AR expression was assessed in these cells by quantitative RT-PCR (qPCR) and Western blot procedures and was compared to cultured primary human prostate stromal fibroblasts (PrSC) and to LNCaP prostate cancer cells that are models for AR action in prostate cancer (Figure 1A). Here, AR is linked to prostate carcinoma.